| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/1071576031000102141 |
| P698 | PubMed publication ID | 12911275 |
| P2093 | author name string | Junji Yodoi | |
| Hajime Nakamura | |||
| Gotaro Yamada | |||
| Gouichi Niiyama | |||
| Kazumi Togawa | |||
| Miwa Kawanaka | |||
| Sabina Mahmood | |||
| Takayo Sasagawa | |||
| Miho Sho | |||
| Misako Okita | |||
| Toshio Ito | |||
| P2860 | cites work | Redox regulation of cellular activation | Q34425412 |
| Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation | Q35451653 | ||
| Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma | Q41629412 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon | Q42993418 | ||
| Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial | Q42995489 | ||
| Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses | Q43041349 | ||
| A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. | Q46214913 | ||
| Interferon for non-A, non-B chronic hepatitis | Q58803541 | ||
| Elevation of plasma thioredoxin levels in HIV-infected individuals | Q71163041 | ||
| Immunological mechanism of chronic liver injury in viral hepatitis | Q71626639 | ||
| Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration | Q71650797 | ||
| Diminished plasma levels of vitamin E in patients with severe viral hepatitis | Q71850855 | ||
| Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study | Q74141609 | ||
| P433 | issue | 7 | |
| P921 | main subject | viral hepatitis | Q1983841 |
| P304 | page(s) | 781-785 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Free Radical Research | Q5500025 |
| P1476 | title | Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C. | |
| P478 | volume | 37 |
| Q37627117 | Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. |
| Q37055955 | An analysis of risk factors for developing Hepatocellular carcinoma in a group of Hepatitis C patients with stage 3 fibrosis following interferon therapy |
| Q24235796 | Antioxidant supplements for liver diseases |
| Q35585469 | Antioxidants as therapeutic agents for liver disease |
| Q34279897 | Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami |
| Q46709785 | Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. |
| Q34411345 | Complementary and alternative medications in hepatitis C infection. |
| Q33370676 | Complementary treatments of chronic viral hepatitis C |
| Q35800315 | Hepatitis C virus to hepatocellular carcinoma. |
| Q61449564 | Improvement of Serum Biochemical Parameters and Hematological Indices Through α-Tocopherol Administration in Dietary Oxidized Olive Oil Induced Toxicity in Rats |
| Q51910766 | Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. |
| Q35039848 | Nutritional therapy and infectious diseases: a two-edged sword |
| Q36316956 | Pathophysiological basis for antioxidant therapy in chronic liver disease |
| Q37324402 | Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma |
| Q26853520 | Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy |
| Q38166445 | Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy |
| Q92855971 | The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
| Q50576318 | Treatment of chronic hepatitis C in non-responsive patients with pegylated interferon associated with ribavirin and thalidomide: report of six cases of total remission. |
| Q37636497 | Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study |
Search more.